Brind.
  1. A meeting regarding SMA research and clinical care was held in Anaheim, involving Biogen.

Biogen announced on June 25, 2025, that it is developing treatments for spinal muscular atrophy (SMA) and has results from Cambridge to be presented at a meeting in Anaheim.

1 report, 0 independent Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Biogen announced on June 25, 2025, that it is developing treatments for spinal muscular atrophy (SMA) and has results from Cambridge to be presented at a meeting in Anaheim.

Who's involved

What this event is mainly about
Biogen

Keep exploring

Part of

A meeting regarding SMA research and clinical care was held in Anaheim, involving Biogen. All 1 developments

The entities involved

  • Biogen

    American multinational biotechnology company

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped
  • Unknown outlet